Can ketamine stop PTSD nightmares?

We cannot promise that. The strongest ketamine trial in chronic PTSD, published by Feder and colleagues in 2021, found improvement in the intrusion symptom cluster, which includes nightmares, but its main results were not reported for nightmares on their own. Imagery rehearsal therapy and prazosin have more direct nightmare data and are usually tried first. Ketamine is off-label for PTSD and may help some people as part of a broader plan.

Do I need to stop prazosin before a ketamine infusion?

Please do not change it on your own. Tell us about prazosin and any other blood pressure medications at your consultation, because ketamine usually raises blood pressure during an infusion and prazosin lowers it. We coordinate with your prescribing provider, and Marla Peterson, CRNA, oversees every infusion with anesthesia-level monitoring of blood pressure, heart rate, and oxygen levels throughout.

How is ketamine different from imagery rehearsal therapy or prazosin?

Imagery rehearsal therapy and prazosin target nightmares directly. Ketamine is a broader treatment whose effect on sleep, if any, appears to be indirect, and its use for PTSD is off-label. The 2023 VA/DoD guideline suggests prazosin for PTSD nightmares, finds insufficient evidence for or against imagery rehearsal therapy, and suggests against ketamine for PTSD, each with low or very low confidence in the evidence.

Will ketamine give me more nightmares?

Many people have vivid or unusual dreams for a night or two after an infusion, and these usually fade within days. That is different from trauma nightmares getting worse. If your usual nightmares become more frequent or intense during a course, tell us and your therapist, and we can slow down, adjust the plan, or pause.

How long would it take to know whether my sleep is changing?

Most people begin with six infusions over two to three weeks. Keeping a simple log of nights with nightmares during and after the series gives you a clear comparison. In the Feder 2021 trial, responders kept their response for a median of 27.5 days after the series, so we look at how long any change lasts, not just whether it appears.

Ketamine for trauma nightmares: what the sleep evidence does and doesn't show

Why trauma nightmares are different from ordinary bad dreams

Most people have a bad dream now and then. Trauma nightmares are something else. They tend to come back, they often carry the same fear or the same scene, and many people wake from them with a pounding heart, soaked sheets, and no chance of falling back asleep. Over time, some people start avoiding sleep itself, which leaves them exhausted and more reactive the next day. That cycle is part of why nightmares can feel like the symptom that runs everything else.

Recurrent distressing dreams are listed among the intrusion symptoms of PTSD, alongside flashbacks and unwanted memories. They are also common. In the National Vietnam Veterans Readjustment Study, a nationally representative sample, frequent nightmares showed up almost exclusively in veterans who had current PTSD, and the authors concluded that frequent nightmares “appear to be virtually specific for PTSD” (Neylan and colleagues, American Journal of Psychiatry, 1998). The VA’s National Center for PTSD, summarizing that work, notes that 52% of combat veterans with PTSD reported significant nightmares, and that 71% of people with PTSD in a separate community sample endorsed them.

Trauma nightmares are also more likely than ordinary dreams to replay the event, or its emotional core. That matters for treatment. A symptom this specific has treatments aimed squarely at it, and those treatments come before anything experimental.

Imagery rehearsal therapy: a treatment aimed squarely at the nightmare

Imagery rehearsal therapy, usually called IRT, is simple on paper. With a trained clinician, you choose a recurring nightmare, write a changed version of it while you are awake and safe, and then rehearse the new version in your imagination for a few minutes each day. You do not have to relive the original in detail. The idea is that the brain can learn a new script for a dream it has been running on repeat.

The best-known trial is Krakow and colleagues’ 2001 randomized controlled trial in JAMA. It enrolled 168 women with PTSD and chronic nightmares, nearly all of whom had survived sexual assault. Eighty-eight received three sessions of IRT and 80 were placed on a wait-list. The IRT group had large reductions in nights per week with nightmares (Cohen’s d = 1.24), improved sleep quality on the Pittsburgh Sleep Quality Index (d = 0.67), and meaningful drops in PTSD symptoms, while the wait-list group changed little.

In 2018, the American Academy of Sleep Medicine published a position paper in the Journal of Clinical Sleep Medicine (Morgenthaler and colleagues) that recommended image rehearsal therapy for PTSD-associated nightmares and nightmare disorder. The 2023 VA/DoD Clinical Practice Guideline for PTSD is more cautious. It found insufficient evidence to recommend for or against IRT, pointing out that among four randomized trials in PTSD populations, only the Krakow trial showed a clear benefit on nightmares, and one larger trial in veterans found no effect. Reasonable experts read the same studies differently. What is not in dispute is that IRT is low-risk, brief, and built for this exact problem. If you have a therapist, it is worth asking whether they offer it. Our guide to finding an integration therapist in Tennessee can help if you are starting from scratch.

Prazosin, the 2018 null trial, and a guideline that still suggests it

Prazosin is an older blood pressure medication that blocks alpha-1 adrenergic receptors, part of the body’s adrenaline system. Several smaller trials in veterans suggested it could quiet trauma nightmares, and for years it was widely prescribed for exactly that.

Then came the largest test. Raskind and colleagues published a VA Cooperative Studies Program trial in the New England Journal of Medicine in 2018: 304 veterans with chronic PTSD and frequent nightmares, 13 VA medical centers, 26 weeks of prazosin or placebo. At 10 weeks there was no significant difference between groups in distressing dreams, sleep quality, or overall clinical change, and no difference at 26 weeks either.

You might expect that to settle it. It did not. The 2023 VA/DoD guideline still suggests prazosin for nightmares associated with PTSD (Recommendation 32, a weak recommendation with low confidence in the evidence), because systematic reviews that included the 2018 trial still found an overall benefit on nightmares. The same guideline suggests against prazosin as a stand-alone treatment for PTSD in general. The honest summary is that prazosin helps some people with nightmares and not others, and it can cause dizziness or a drop in blood pressure on standing. Whether it belongs in your plan is a conversation for you and your prescribing provider.

What ketamine research actually shows about sleep and PTSD

Ketamine is FDA-approved as an anesthetic; its use for PTSD, including PTSD-related nightmares, is off-label. At the low doses used for mental health, ketamine blocks NMDA glutamate receptors, which is followed by a surge of glutamate signaling and a period of increased synaptic plasticity. Researchers have proposed that this window may help loosen rigid fear responses. That is a hypothesis, not a proven route to better sleep. You can read more in how ketamine works.

The strongest PTSD evidence comes from a 2021 randomized trial in the American Journal of Psychiatry by Feder and colleagues. Thirty adults with chronic PTSD received six infusions of ketamine or midazolam over two weeks. At week two, the ketamine group scored 11.88 points lower on the CAPS-5, and 67% were responders compared with 20% on midazolam. The researchers reported marked improvement in three of four symptom clusters: intrusions, avoidance, and negative changes in mood and thinking. Nightmares sit inside the intrusion cluster, but the headline results were reported as total and cluster scores rather than nightmares on their own, and the arousal cluster, which includes sleep disturbance, was not among those showing marked improvement.

A larger trial pointed the other way. Abdallah and colleagues, writing in Neuropsychopharmacology in 2022, randomized 158 veterans and service members with PTSD to eight infusions of low-dose ketamine, standard-dose ketamine, or placebo. There was no significant difference in PTSD symptoms between groups, although the standard dose improved depression. The 2023 VA/DoD guideline, weighing trials like these, suggests against ketamine for PTSD (a weak recommendation, with very low confidence in the evidence).

Direct sleep data are thinner still. A 2025 analysis in the European Journal of Trauma & Dissociation (Almog and colleagues) surveyed 202 patients receiving ketamine in real-world clinics, 98 of whom had PTSD. Patients with PTSD reported worse sleep before treatment and improvements comparable to patients without PTSD. That is encouraging, but it was an anonymous, retrospective self-report survey with no control group. We are not aware of a published randomized trial that has made trauma nightmares its primary outcome. So the fair statement is this: ketamine may help some people with PTSD overall, and sleep may improve along with that, but the evidence that it treats nightmares specifically is limited and indirect.

Vivid dreams after an infusion are a different phenomenon

Many patients notice unusually vivid, detailed, or strange dreams in the first few nights after an infusion. This is a separate thing from trauma nightmares, and it is worth keeping the two apart. Post-infusion dreams are usually short-lived, often neutral or even interesting, and not a sign that treatment is or is not working. We cover them in depth in vivid dreams after ketamine, and ketamine and sleep the night after walks through what that first night tends to look like. For the broader picture of rest and recovery, see ketamine and sleep.

What we want to hear about is different: your usual trauma nightmares becoming more frequent or more intense during a course, new intrusive imagery, or starting to dread going to sleep. That is uncommon, but if it happens, tell us and your therapist. We can slow down, adjust the plan, or pause. Our article on whether ketamine can cause flashbacks addresses a closely related fear.

How we approach nightmare-heavy PTSD at Music City Ketamine

When sleep is the main complaint, our consultation spends real time on it. We ask how many nights a week you have nightmares, whether you avoid sleep, what you have already tried, and what medications you take, including prazosin or other blood pressure medications, because ketamine usually raises blood pressure during an infusion and we plan around that. We also ask about snoring and daytime sleepiness, since untreated sleep apnea can fragment sleep on its own; ketamine and sleep apnea explains why.

For trauma presentations, we generally recommend having a therapist in place before starting, ideally one who can offer trauma-focused therapy or IRT. If you decide to go ahead, we suggest keeping a simple sleep log, just the number of nights with nightmares each week, so that you, your therapist, and we are judging change by the same yardstick. You do not have to tell us what your nightmares are about. Our approach to trauma-informed ketamine care explains how we handle disclosure, choice, and control in the room.

Marla Peterson, CRNA, oversees every infusion, with anesthesia-level monitoring throughout, including continuous pulse oximetry, blood pressure, and heart rate. A clinician is in the room and the team is on-site throughout. For more on the safety setup, see is ketamine therapy safe?

Honest expectations

We cannot promise that ketamine will stop your nightmares, and we would be wary of any clinic that does. Imagery rehearsal therapy and prazosin are the treatments with direct nightmare data, and trauma-focused therapy remains the foundation of PTSD care. Ketamine may be worth considering when those have not been enough, as a support to that work rather than a replacement for it. Some people do not respond. For those who do, the benefit may fade: in the Feder 2021 trial, responders kept their response for a median of 27.5 days after the two-week series, which is why many people plan for follow-up or maintenance sessions.

Please do not start, stop, or change any medication, including prazosin, on your own; any change belongs with your prescribing provider. Sessions are $475 each, and insurance generally does not cover off-label use. If you want the wider context, our trauma and PTSD pages bring related articles together, including ketamine for PTSD and ketamine for complex PTSD.